Abecma

Bristol Myers Squibb
Manufacturing

BMS calls it quits on vector production at former Novartis plant

Two years after securing a former Novartis gene therapy facility in Illinois, Bristol Myers Squibb is rethinking its operations at the site.
Fraiser Kansteiner May 2, 2025 11:20am
graphic of a larger shark chomping up a smaller one

BMS buys cell therapy partner 2seventy bio for $286M

Mar 11, 2025 10:12am
New Year 2025

Pfizer, BMS and more start 2025 with drug price hikes: report

Jan 2, 2025 10:42am
Marks

FDA revisits CAR-T boxed warning on secondary cancers: Marks

Nov 1, 2024 10:30am
target reach ladder climb meet win beat competition

J&J, Legend's Carvykti shows 45% survival benefit in myeloma

Sep 30, 2024 9:50am
Stop sign

BMS, 2seventy scrap Abecma trial in first-line multiple myeloma

Sep 25, 2024 10:52am